Home › Myotonic Dystrophy › Virginia › Richmond
Myotonic Dystrophy clinical trials in Richmond, VA
8 studies for Myotonic Dystrophy are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
RecruitingPhase 3
- Virginia Commonwealth University - Biotech One, Richmond
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
RecruitingPhase 1/2
- Virginia Commonwealth University Medical Center- Site Number : 8400006, Richmond
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
RecruitingObservational study
- Virginia Commonwealth University, Richmond
Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
RecruitingObservational study
- Virginia Commonwealth University, Richmond
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
RecruitingObservational study
- Virginia Commonwealth University, Richmond
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
RecruitingObservational study
- Virginia Commonwealth University, Richmond
Study of ATX-01 in Participants With DM1
RecruitingPhase 1/2
- Virginia Commonwealth University, Richmond
Long-Term Development of Muscular Dystrophy Outcome Assessments
RecruitingObservational study
- Virginia Commonwealth University, Richmond
Myotonic Dystrophy trials in other cities
- Rochester, NY7 studies
- Boston, MA4 studies
- Los Angeles, CA4 studies
- Cedar Rapids, IA3 studies
- Gainesville, FL3 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Cardiovascular Disease13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Metastatic Cancer12 studies
- Melanoma11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.